Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6270-6277

  Schultz, Chad ^a   Lemke, Nancy ^a   Ge, Shugang ^a   Golembieski, William A ^a   Rempel, Sandra A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; OSTEONECTIN; PARAFFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CLONE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONCENTRATION RESPONSE; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; GLIOMA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; RAT STRAIN; STEREOTAXIC SURGERY; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036829855     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rempel, S. A., Golembieski, W. A., Ge, S., Lemke, N., Elisevich, K., Mikkelsen. T., and Gutiérrez, J. A. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J. Neuropathol. Exp. Neurol., 57: 1112-1121, 1998.
2. Bradshaw, A. D., and Sage, E. H., SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Investig., 107: 1049-1054, 2001.
3. Greenwood, J. A., and Murphy-Ullrich, J. E. Signaling of de-adhesion in cellular regulation and motility. Microsc. Res. Tech., 43: 420-432, 1998.
4. Funk, S. E., and Sage, E. H. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J. Cell Physiol., 154: 53-63, 1993.
5. Raines, E. W., Lane, T. F., Iruele-Arispe, M. L., Ross, R., and Sage, E. H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. USA. 89: 1281-1285, 1992.
6. Kupprion, C., Motamed, K., and Sage, E. H. SPARC (BM-40. osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem., 273: 29635-29640, 1998.
7. Hasselaar, P., and Sage, E. H. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J. Cell. Biochem., 49: 272-283, 1992.
8. Mundlos, S., Schwahn, B., Reichert, T., and Zabel, B. Distribution of osteonectin mRNA and protein during human embryonic and fetal development. J. Histochem. Cytochem., 40: 283-291, 1992.
9. Reed, M. J., Puolakkainen, P., Lane, T. F., Dickerson, D., Bornstein, P., and Sage, E. H. Differential expression of SPARC and thrombospondin I in wound repair: Immunolocalization and in situ hybridization. J. Histochem. Cytochem., 41: 1467-1477, 1993.
10. Ledda, M. F., Adris, S., Bravo, A. I., Kairiyama, C., Bover, L., Chemajovsky, Y., Mordoh, J., and Podhajcer, O. L. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat. Med., 3: 171-176, 1997.
11. Gilles, C., Bassuk, J. A., Pulyaeva, H., Sage, E. H., Foidart, J-M., and Thompson, E. W. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res., 58: 5529-5536, 1998.
12. Porte, H., Chastre, E., Prevot, S., Nordlinger, B., Empereur, S., Basset, P., Chambon, P., and Gespach, C. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int. J. Cancer, 64: 70-75, 1995.
13. Porte, H., Triboulet, J. P., Kotelevets, L., Carrat, F., Prévot, S., Nordlinger, B., DiGioia, Y., Wurtz, A., Comoglio, P., Gespach, C., and Chastre, E. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: Implications for prognosis. Clin. Cancer Res., 4: 1375-1382, 1998.
14. Jacob, K., Webber, M., Benayahu, D., and Kleinman, H. K. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone. Cancer Res., 59: 4453-4457, 1999.
15. Rempel, S. A., Ge, S., and Gutiérez, J. A. SPARC: a potential diagnostic marker of invasive meningiomas. Clin. Cancer Res., 5: 237-241, 1999.
16. Vajkoczy, P., Menger, M. D., Goldbrunner, R., Ge, S., Fong, T. A., Vollmar, B., Schilling, L., Ullrich, A., Hirth, K. P., Tonn, J. C., Schmiedek, P., and Rempel, S. A. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC. Int. J. Cancer, 87: 261-268, 2000.
17. Golembieski, W. A., Ge, S., Nelson, K., Mikkelsen, T., and Rempel, S. A. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int. J. Dev. Neurosci., 17: 463-472, 1999.
18. Rempel, S. A., Golembieski, W. A., Fisher, J. L., Maile, M., and Nakeff, A. SPARC modulates cell growth, attachment and migration of U87 Glioma cells on brain extracellular matrix proteins. J. Neurooncol., 53: 149-160, 2001.
19. Uitto, V. J., Firth, J. D., Nip, L., and Golub, L. M. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann. NY Acad. Sci., 732: 140-151, 1994.
20. Golembieski, W. A., and Rempel, S. A. cDNA array analysis of SPARC-modulated changes in glioma gene expression. J. Neurooncol., in press, 2002.
21. Giese, A., Loo, M. A., Tran, N., Haskett, D., Coons, S. W., and Berens, M. E. Dichotomy of astrocytoma migration and proliferation. Int. J. Cancer, 67: 275-282, 1996.
22. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Nat. Acad. Sci. USA. 88:2648-2652, 1991.